Organogenesis Holdings Inc

(NASDAQ:ORGO)

Latest On Organogenesis Holdings Inc (ORGO):

Date/Time Type Description Signal Details
2023-05-11 23:19 ESTNewsOrganogenesis surges ~30% as Wound Care drives Q1 revenue; raises FY23 outlookN/A
2023-05-11 09:05 ESTNewsOrganogenesis Holdings Inc. (ORGO) Q1 2023 Earnings Call TranscriptN/A
2023-05-10 19:14 ESTNewsOrganogenesis Holdings reports Q1 results, raises FY 2023 revenue guidanceN/A
2023-05-10 05:58 ESTNewsOrganogenesis Holdings Q1 2023 Earnings PreviewN/A
2023-04-27 08:34 ESTNewsOrganogenesis President and CEO, also named to Chair of the BoardN/A
2023-03-02 20:21 ESTNewsOrganogenesis' reports positive interim analysis of Phase 3 ReNu trial for knee painN/A
2023-03-02 05:29 ESTNewsOrganogenesis Holdings reports Q4 results, introduces FY 2023 revenue guidanceN/A
2023-03-02 05:29 ESTNewsOrganogenesis Holdings Inc. (ORGO) Q4 2022 Earnings Call TranscriptN/A
2023-02-28 23:53 ESTNewsOrganogenesis Holdings Q4 2022 Earnings PreviewN/A
2023-02-09 14:25 ESTNewsOrganogenesis: Quantifying The OpportunityN/A
2022-11-10 04:13 ESTNewsOrganogenesis Holdings GAAP EPS of $0.00, revenue of $116.9M, guidance below consensusN/A
2022-11-09 10:22 ESTNewsOrganogenesis Holdings Q3 2022 Earnings PreviewN/A
2022-10-18 08:02 ESTNewsOrganogenesis: Finding A Spot For This Regenerative Medicines Company In My 'Bio Boom' PortfolioN/A
2022-08-15 19:54 ESTNewsOrganogenesis gets FDA clearance for PuraPly MZ for wound healingN/A
2022-08-10 04:11 ESTNewsOrganogenesis Holdings reports Q2 earnings; narrows FY22 guidanceN/A
2022-08-10 04:11 ESTNewsOrganogenesis Holdings Inc. (ORGO) CEO Gary Gillheeney on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-09 06:21 ESTNewsOrganogenesis Holdings Q2 2022 Earnings PreviewN/A
2022-05-19 06:40 ESTNewsOrganogenesis Holdings: What NowN/A
2022-05-11 07:38 ESTNewsOrganogenesis Holdings GAAP EPS of $0.00 misses by $0.05, revenue of $98.12M beats by $2.4MN/A
2022-05-11 07:37 ESTNewsOrganogenesis Holdings Inc. (ORGO) CEO Gary Gillheeney on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 11:36 ESTNewsOrganogenesis Q1 Earnings PreviewN/A
2022-03-20 12:28 ESTNewsOrganogenesis Holdings (ORGO) Investor Presentation - SlideshowN/A
2022-03-02 21:38 ESTNewsOrganogenesis gains the most in over a year after strong Q4 earnings beatN/A
2022-03-02 05:00 ESTNewsOrganogenesis Holdings GAAP EPS of $0.39 beats by $0.29, revenue of $128.56M beats by $4.19MN/A
2022-03-02 05:00 ESTNewsOrganogenesis Holdings Inc. (ORGO) CEO Gary Gillheeney on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 11:05 ESTNewsOrganogenesis Holdings Q4 2021 Earnings PreviewN/A
2021-11-10 13:37 ESTNewsOrganogenesis Holdings Inc. (ORGO) CEO Gary Gillheeney on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-09 14:32 ESTNewsOrganogenesis Holdings Q3 2021 Earnings PreviewN/A
2021-10-15 18:52 ESTNewsOrganogenesis defended at BTIG after short report caused selloffN/A
2021-10-13 06:01 ESTNewsOrganogenesis falls on anonymous short reportN/A
2021-08-10 09:28 ESTNewsOrganogenesis Holdings EPS beats by $0.10, beats on revenueN/A
2021-08-10 09:28 ESTNewsOrganogenesis Holdings' (ORGO) CEO Gary Gillheeney on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-21 19:08 ESTNewsOrganogenesis jumps 12% on addition to SmallCap 600; CROX dips on moveN/A
2021-03-18 17:21 ESTFinancialsCompany financials have been released.Neutral
2021-03-18 13:19 ESTAnalyst RatingThe Analyst Target Price has increased from $17.5 to $21.Buy
2021-03-17 13:24 ESTEarnings EstimateAn EPS average of $0.25 is estimated for the 2022 year.Buy
2021-03-17 13:24 ESTEarnings EstimateAn EPS average of -$0.03 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-17 05:39 ESTNewsOrganogenesis Holdings EPS beats by $0.03, beats on revenueN/A
2021-03-17 05:39 ESTNewsOrganogenesis Holdings Inc. (ORGO) CEO Gary Gillheeney on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-16 21:40 ESTAnalyst RatingThe Analyst Target Price has increased from $14.5 to $17.5.Neutral
2021-02-25 14:03 ESTAnalyst RatingThe Analyst Target Price has increased from $13 to $14.5.Neutral
2021-02-23 04:19 ESTAnalyst RatingThe Analyst Target Price has increased from $12.25 to $13.Buy
2021-01-21 12:27 ESTAnalyst RatingThe Analyst Target Price has increased from $11.5 to $12.25.Buy
2021-01-18 08:14 ESTAnalyst RatingThe Analyst Target Price has increased from $10.5 to $11.5.Buy
2021-01-15 08:18 ESTAnalyst RatingThe Analyst Target Price has increased from $9.5 to $10.5.Buy
2021-01-14 23:43 ESTNewsEnrollment underway in Organogenesis' late-stage study with amniotic allograft for knee OAN/A
2021-01-13 17:17 ESTNewsOrganogenesis +23% AH, expects revenue to rise 40-42% Y/YN/A
2021-01-11 21:32 ESTNewsOrganogenesis' ReNu wins FDA's RMAT statusN/A
2021-01-08 08:18 ESTAnalyst RatingThe Analyst Target Price has increased from $9.25 to $9.5.Buy
2020-12-27 03:19 ESTNewsOrganogenesis Holdings: Accumulate On DipsN/A

About Organogenesis Holdings Inc (ORGO):

Organogenesis Holdings Inc., a regenerative medicine company, focuses on the development, manufacture, and commercialization of solutions for the advanced wound care, and surgical and sports medicine markets primarily in the United States. The company's advanced wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for treating DFUs; PuraPly AM to address biofilm across a range of wound types; and Affinity and NuShield to address various wound sizes and types. Its surgical and sports medicine products comprise ReNu for in-office joint and tendon applications; NuCel for bony fusion in the spine and extremities; NuShield and Affinity for surgical applications in targeted soft tissue repairs; and PuraPly AM for the surgical treatment of open wounds. The company's pipeline products include TransCyte for the treatment of second- and third-degree burns; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; Novachor for the treatment of chronic and acute wounds; Gintuit for the treatment of mucogingival conditions in adults; and PuraPly XT and PuraPly MZ for the treatment of chronic and acute wounds, as well as for surgical treatment of open wounds. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician offices. The company sells its products through direct sales representatives and independent agencies. Organogenesis Holdings Inc. was founded in 1985 and is headquartered in Canton, Massachusetts.

ORGO Quotes by TradingView

See Advanced Chart

General

  • Name Organogenesis Holdings Inc
  • Symbol ORGO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 835
  • Fiscal Year EndDecember
  • IPO Date2017-01-05
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://organogenesis.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 5.96
  • Price/Book (Most Recent Quarter) 34.56
  • Enterprise Value Revenue 6.67
  • Enterprise Value EBITDA 60.62
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Current Year EPS Estimate $0.11
  • Next Year EPS Estimate $0.23
  • Next Quarter EPS Estimate -$0.10
  • Profit Margin 5%
  • Operating Margin 8%
  • Return on Assets 7%
  • Return on Equity 18%
  • Revenue 338.3 million
  • Earnings Per Share -$0.58
  • Revenue Per Share $3.14
  • Gross Profit 250.98 million
  • Quarterly Earnings Growth 43.1%
View More

Highlights

  • Market Capitalization 2.26 billion
  • EBITDA 35.7 million
  • PE Ratio -23.08
  • Analyst Target Price $21
  • Book Value Per Share $0.61
View More

Share Statistics

  • Shares Outstanding 127.99 million
  • Shares Float 28.85 million
  • % Held by Insiders 5551%
  • % Held by Institutions 27.48%
  • Shares Short 586932
  • Shares Short Prior Month 1.04 million
  • Short Ratio 0.82
  • Short % of Float 1%
View More

Technicals

  • Beta 1.6
  • 52 Week High $18.41
  • 52 Week Low $2.69
  • 50 Day Moving Average 14.12
  • 200 Day Moving Average 7.5
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Organogenesis Holdings Inc (ORGO) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Organogenesis Holdings Inc (ORGO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312020-12-31$N/A$0.15$0.1315.38%
2020-09-302020-11-09$N/A$0.19-$0.07371.43%
2020-06-302020-08-10$N/A-$0.05-$0.2377.78%
2020-03-312020-05-11$61.73 million-$0.16-$0.13-20.3%
2019-12-312020-03-09$74.65 million-$0.04-$0.0957.36%
2019-09-302019-11-12$64.27 million-$0.12-$0.134.99%
2019-06-302019-08-09$64.95 million-$0.11-$0.1315.38%
2019-03-312019-05-10$57.12 million-$0.17-$0.11-55.96%
2018-12-312019-03-18$63.6 million-$0.12
2018-09-302018-11-14$50.77 million$0.10
2018-06-302018-08-13$39.54 million-$0.09
2018-03-312018-05-14$35.53 million-$0.11
2017-12-312018-02-28$15.79 million-$0.13
2017-09-302017-11-15$6.3 million-$0.30
2017-06-302017-08-14$0.04
2017-03-312017-05-15$0.02
2016-12-312017-03-01-$0.02

Organogenesis Holdings Inc (ORGO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development N/A N/A N/A 5.41 million 3.64 million
Income Before Tax N/A N/A N/A -16.28 million -4.36 million
Selling General Administrative N/A N/A N/A 52.61 million 52.37 million
Gross Profit N/A N/A N/A 42.94 million 54.25 million
Ebit N/A N/A N/A -12.05 million -1.75 million
Operating Income N/A N/A N/A -15.08 million -1.75 million
Income Tax Expense 396000 72000 27000 N/A 42000
Total Revenue N/A N/A N/A 61.73 million 74.65 million
Cost of Revenue N/A N/A N/A 18.79 million 20.39 million
Total Other Income Expense Net N/A N/A N/A 1.32 million -2.6 million
Net Income From Continuing Operations N/A N/A N/A -16.31 million -4.4 million
Net Income Applicable to Common Shares 18.49 million 20.93 million -5.17 million N/A -4.4 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A -4.24 million N/A N/A
Change to Liabilities -4.01 million 2.15 million N/A -648000 3.88 million
Total Cash Flow from Investing Activities -10.24 million -1.88 million N/A -3.46 million -1.28 million
Net Borrowings -627000 5.26 million N/A -403000 9.69 million
Total Cash Flow from Financial Activities N/A N/A 8.23 million 47.07 million 9.73 million
Change to Operating Activities 1.31 million 4.35 million N/A 2.72 million -217000
Change in Cash N/A N/A -13.3 million 37.21 million 3 million
Total Cash from Operating Activities 7.14 million -9.34 million -17.28 million -6.4 million -5.45 million
Depreciation N/A N/A 1.72 million 2.35 million 2.32 million
Other Cash Flow from Investing Activities 1.43 million 293000 N/A N/A N/A
Change to Inventory N/A N/A -4.29 million -3.22 million -1.75 million
Change to Account Receivables N/A N/A 6.33 million -5.24 million -170000
Other Cash Flow from Financing Activities -466000 -526000 N/A -2.97 million -75000
Change to Net Income 909000 2.74 million N/A 2.04 million 1.23 million
Capital Expenditures N/A N/A 4.24 million 3.46 million 1.28 million
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities N/A N/A N/A 168.05 million 165.1 million
Total Stockholder Equity N/A N/A N/A 40.3 million 55.58 million
Other Current Liabilities 578000 966000 N/A 5.34 million 5 million
Total Assets N/A N/A N/A 208.34 million 220.69 million
Common Stock 13000 11000 11000 N/A 10000
Other Current Assets 412000 374000 N/A N/A 196000
Retained Earnings -153.06 million -171.55 million -192.49 million -187.32 million -171.01 million
Other Liabilities 15.71 million 15.12 million 9.36 million N/A 7.66 million
Other Assets 688000 716000 1.05 million N/A 1.57 million
Cash N/A N/A N/A 46.9 million 60.17 million
Total Current Liabilities 68.22 million 66.25 million N/A 54.83 million 59.89 million
Other Stockholder Equity N/A N/A N/A N/A N/A
Property, Plant & Equipment 60.07 million 55.94 million 53.03 million N/A 47.18 million
Total Current Assets 174.34 million 129.01 million N/A 111.4 million 125.6 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 86.69 million 4.71 million -8.95 million N/A 9.25 million
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt N/A N/A N/A 91.39 million 83.12 million
Inventory 27.8 million 29.88 million N/A 26.44 million 22.92 million
Accounts Payable 23.38 million 24.01 million N/A 26.21 million 28.39 million

Organogenesis Holdings Inc (ORGO) Chart:

Organogenesis Holdings Inc (ORGO) News:

Below you will find a list of latest news for Organogenesis Holdings Inc (ORGO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Organogenesis Holdings Inc (ORGO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-05-162.52CALL0 25424.6TRUE00
2025-05-1650.25CALL100 18106.79FALSE0.250
2025-05-167.50.1CALL0 1192.87FALSE00
2025-05-16100CALL0 0295.31FALSE00
2025-05-162.50.1PUT0 1167.48FALSE00
2025-05-1651.05PUT0 5136.72TRUE00
2025-05-167.50PUT0 0399.63TRUE00
2025-05-16100PUT0 0196.52TRUE00
2025-06-202.50CALL0 0284.7TRUE00
2025-06-2050CALL0 0412.66FALSE00
2025-06-207.50CALL0 0472.39FALSE00
2025-06-202.50PUT0 01200.23FALSE00
2025-06-2050PUT0 0284.13TRUE00
2025-06-207.50PUT0 0103.31TRUE00
2025-07-182.51.19CALL0 22246.97TRUE00
2025-07-1850.6CALL0 197163.82FALSE00
2025-07-187.50.3CALL0 96126FALSE00
2025-07-18100.3CALL0 1306.34FALSE00
2025-07-182.50.2PUT0 53115.06FALSE00
2025-07-1851.35PUT0 397.34TRUE00
2025-07-187.50PUT0 098.96TRUE00
2025-07-18104.6PUT0 0140.11TRUE00
2025-10-172.51.5CALL0 10265.09TRUE00
2025-10-1750.89CALL0 36108.54FALSE00
2025-10-177.50.4CALL3 3893.34FALSE0.40
2025-10-17100.1CALL0 12116.24FALSE00
2025-10-172.50.1PUT0 24125.52FALSE00
2025-10-1751.7PUT3 9105.11TRUE-0.1-0.06
2025-10-177.52.55PUT0 1140.69TRUE00
2025-10-17100PUT0 0145.61TRUE00

Latest ORGO Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST309$4.915
Jun 13, 2022 7:59 PM EST100$4.915
Jun 13, 2022 7:59 PM EST85$4.92
Jun 13, 2022 7:59 PM EST200$4.92
Jun 13, 2022 7:59 PM EST39$4.92

Organogenesis Holdings Inc (ORGO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661181/000119312520139057/0001193125-20-139057-index.htm
2019-09-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1661181/000000000019013376/0000000000-19-013376-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661181/000090266419001032/0000902664-19-001032-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661181/000090266419001071/0000902664-19-001071-index.htm
2019-04-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661181/000090266419002056/0000902664-19-002056-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661181/000090266420001027/0000902664-20-001027-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661181/000101143819000067/0001011438-19-000067-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661181/000106299319000724/0001062993-19-000724-index.htm
2018-12-20SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1661181/000110465918074126/0001104659-18-074126-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000114036118045047/0001140361-18-045047-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000114036118045048/0001140361-18-045048-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000114036118045050/0001140361-18-045050-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000114036118045052/0001140361-18-045052-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000114036118045055/0001140361-18-045055-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000114036118045056/0001140361-18-045056-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000114036118045058/0001140361-18-045058-index.htm
2019-08-21SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1661181/000114036119015432/0001140361-19-015432-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000114036119015434/0001140361-19-015434-index.htm
2019-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000114036119016217/0001140361-19-016217-index.htm
2019-09-09SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1661181/000114036119016314/0001140361-19-016314-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000114036119016483/0001140361-19-016483-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000114036119016669/0001140361-19-016669-index.htm
2019-11-27SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1661181/000114036119021630/0001140361-19-021630-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000114036119021634/0001140361-19-021634-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000114036120005973/0001140361-20-005973-index.htm
2018-12-148-K12G3Notification of securities of successor issuers deemed to registered [Section 12]https://www.sec.gov/Archives/edgar/data/1661181/000119312518349998/0001193125-18-349998-index.htm
2018-12-20SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1661181/000119312518354631/0001193125-18-354631-index.htm
2018-12-24S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661181/000119312518356599/0001193125-18-356599-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312519003236/0001193125-19-003236-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312519003890/0001193125-19-003890-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312519003898/0001193125-19-003898-index.htm
2019-01-10S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661181/000119312519005544/0001193125-19-005544-index.htm
2019-01-15S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661181/000119312519009137/0001193125-19-009137-index.htm
2019-01-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312519023040/0001193125-19-023040-index.htm
2019-02-04424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1661181/000119312519026480/0001193125-19-026480-index.htm
2019-02-11POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1661181/000119312519033145/0001193125-19-033145-index.htm
2019-02-11S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1661181/000119312519033971/0001193125-19-033971-index.htm
2019-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312519034755/0001193125-19-034755-index.htm
2019-02-14424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1661181/000119312519040965/0001193125-19-040965-index.htm
2019-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312519071061/0001193125-19-071061-index.htm
2019-03-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312519074833/0001193125-19-074833-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312519078270/0001193125-19-078270-index.htm
2019-03-1810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1661181/000119312519078332/0001193125-19-078332-index.htm
2019-03-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312519078641/0001193125-19-078641-index.htm
2019-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312519080044/0001193125-19-080044-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312519094515/0001193125-19-094515-index.htm
2019-04-3010-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1661181/000119312519129342/0001193125-19-129342-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312519143609/0001193125-19-143609-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661181/000119312519143616/0001193125-19-143616-index.htm
2019-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312519154144/0001193125-19-154144-index.htm
2019-07-12PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1661181/000119312519193315/0001193125-19-193315-index.htm
2019-07-12SC TO-ITender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1661181/000119312519193316/0001193125-19-193316-index.htm
2019-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312519194343/0001193125-19-194343-index.htm
2019-07-16SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1661181/000119312519194344/0001193125-19-194344-index.htm
2019-07-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1661181/000119312519199020/0001193125-19-199020-index.htm
2019-07-22SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1661181/000119312519199027/0001193125-19-199027-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312519216961/0001193125-19-216961-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312519217408/0001193125-19-217408-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661181/000119312519217411/0001193125-19-217411-index.htm
2019-08-09SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1661181/000119312519218019/0001193125-19-218019-index.htm
2019-08-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312519224552/0001193125-19-224552-index.htm
2019-08-19SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1661181/000119312519224557/0001193125-19-224557-index.htm
2019-08-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312519226120/0001193125-19-226120-index.htm
2019-09-04S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661181/000119312519237746/0001193125-19-237746-index.htm
2019-09-16S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661181/000119312519245823/0001193125-19-245823-index.htm
2019-09-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1661181/000119312519245838/0001193125-19-245838-index.htm
2019-09-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1661181/000119312519249603/0001193125-19-249603-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312519289941/0001193125-19-289941-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661181/000119312519289983/0001193125-19-289983-index.htm
2019-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312519293421/0001193125-19-293421-index.htm
2019-11-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1661181/000119312519295640/0001193125-19-295640-index.htm
2019-11-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312519298549/0001193125-19-298549-index.htm
2019-11-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1661181/000119312519298561/0001193125-19-298561-index.htm
2019-11-27SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1661181/000119312519302479/0001193125-19-302479-index.htm
2019-12-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312519308297/0001193125-19-308297-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312520005910/0001193125-20-005910-index.htm
2020-02-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312520042010/0001193125-20-042010-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312520067174/0001193125-20-067174-index.htm
2020-03-0910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1661181/000119312520067198/0001193125-20-067198-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312520074892/0001193125-20-074892-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312520090922/0001193125-20-090922-index.htm
2020-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312520101356/0001193125-20-101356-index.htm
2020-04-2910-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1661181/000119312520126225/0001193125-20-126225-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312520139049/0001193125-20-139049-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661181/000119312520139057/0001193125-20-139057-index.htm
2020-07-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312520195478/0001193125-20-195478-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312520214924/0001193125-20-214924-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661181/000119312520214949/0001193125-20-214949-index.htm
2020-08-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312520228352/0001193125-20-228352-index.htm
2020-09-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312520245737/0001193125-20-245737-index.htm
2020-10-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312520269432/0001193125-20-269432-index.htm
2020-10-16S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661181/000119312520271238/0001193125-20-271238-index.htm
2020-11-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661181/000119312520284829/0001193125-20-284829-index.htm
2018-12-1425-NSENotification filed by national security exchange to report the removal from listing and registration of matured, redeemed or rethttps://www.sec.gov/Archives/edgar/data/1661181/000135445718000525/0001354457-18-000525-index.htm
2019-03-1225-NSENotification filed by national security exchange to report the removal from listing and registration of matured, redeemed or rethttps://www.sec.gov/Archives/edgar/data/1661181/000135445719000127/0001354457-19-000127-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661181/000145307219000028/0001453072-19-000028-index.htm
2019-05-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118119000001/0001661181-19-000001-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118119000002/0001661181-19-000002-index.htm
2019-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118119000005/0001661181-19-000005-index.htm
2019-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118119000006/0001661181-19-000006-index.htm
2019-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118119000008/0001661181-19-000008-index.htm
2019-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118119000010/0001661181-19-000010-index.htm
2019-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118119000012/0001661181-19-000012-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118119000015/0001661181-19-000015-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118119000016/0001661181-19-000016-index.htm
2019-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118119000019/0001661181-19-000019-index.htm
2019-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118119000020/0001661181-19-000020-index.htm
2019-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118119000021/0001661181-19-000021-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118120000002/0001661181-20-000002-index.htm
2020-04-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118120000004/0001661181-20-000004-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118120000006/0001661181-20-000006-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118120000008/0001661181-20-000008-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118120000010/0001661181-20-000010-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118120000012/0001661181-20-000012-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118120000014/0001661181-20-000014-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118120000016/0001661181-20-000016-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118120000019/0001661181-20-000019-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118120000021/0001661181-20-000021-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118120000023/0001661181-20-000023-index.htm
2020-08-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118120000027/0001661181-20-000027-index.htm
2020-08-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661181/000166118120000029/0001661181-20-000029-index.htm
2019-02-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1661181/999999999519000191/9999999995-19-000191-index.htm
2019-09-23EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1661181/999999999519002154/9999999995-19-002154-index.htm
2019-02-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1661181/999999999719000258/9999999997-19-000258-index.htm

Organogenesis Holdings Inc (ORGO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Organogenesis Holdings Inc (ORGO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 5551%
Institutional Ownership: 2748%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-09-04MICHAEL W KATZ10% Share HolderBuy10,000.004.5044,975.0010,000.00https://www.sec.gov/Archives/edgar/data/1661181/000166118119000008/0001661181-19-000008-index.htm
2019-09-13WAYNE D MACKIEDirectorBuy1,032.006.076,267.54100,000.00https://www.sec.gov/Archives/edgar/data/1661181/000166118119000020/0001661181-19-000020-index.htm
2020-04-22WAYNE D MACKIEDirectorBuy18,564.00118,564.00https://www.sec.gov/Archives/edgar/data/1661181/000166118120000019/0001661181-20-000019-index.htm
2019-09-13MICHAEL W KATZ10% Share HolderBuy3,603.006.0021,618.0013,603.00https://www.sec.gov/Archives/edgar/data/1661181/000166118119000021/0001661181-19-000021-index.htm
2018-12-10Avista Capital Managing Member IV, LLC10% Share HolderBuy6,538,732.0015,561,473.00https://www.sec.gov/Archives/edgar/data/1661181/000114036118045048/0001140361-18-045048-index.htm
2018-12-10David F BurgstahlerPresident & CEOBuy6,538,732.0015,561,473.00https://www.sec.gov/Archives/edgar/data/1661181/000114036118045047/0001140361-18-045047-index.htm
2020-04-22Patrick BilboChief Operating OfficerBuy34,035.00155,835.00https://www.sec.gov/Archives/edgar/data/1661181/000166118120000014/0001661181-20-000014-index.htm
2019-08-19Avista Capital Managing Member IV, LLCDirectorBuy389,501.0016,999,665.00https://www.sec.gov/Archives/edgar/data/1661181/000114036119015434/0001140361-19-015434-index.htm
2019-09-03Avista Capital Managing Member IV, LLCDirectorBuy200,000.004.75949,760.0017,199,665.00https://www.sec.gov/Archives/edgar/data/1661181/000114036119016217/0001140361-19-016217-index.htm
2019-09-04Avista Capital Managing Member IV, LLCDirectorBuy200,000.004.90979,220.0017,399,665.00https://www.sec.gov/Archives/edgar/data/1661181/000114036119016217/0001140361-19-016217-index.htm
2019-09-05Avista Capital Managing Member IV, LLCDirectorBuy177,600.004.89868,570.5617,577,265.00https://www.sec.gov/Archives/edgar/data/1661181/000114036119016217/0001140361-19-016217-index.htm
2019-09-06Avista Capital Managing Member IV, LLCDirectorBuy500,000.005.182,592,300.0018,077,265.00https://www.sec.gov/Archives/edgar/data/1661181/000114036119016483/0001140361-19-016483-index.htm
2019-09-09Avista Capital Managing Member IV, LLCDirectorBuy25,000.005.12128,022.5018,102,265.00https://www.sec.gov/Archives/edgar/data/1661181/000114036119016483/0001140361-19-016483-index.htm
2019-09-10Avista Capital Managing Member IV, LLCDirectorBuy12,000.005.1862,206.8018,114,265.00https://www.sec.gov/Archives/edgar/data/1661181/000114036119016483/0001140361-19-016483-index.htm
2019-09-11Avista Capital Managing Member IV, LLCDirectorBuy447,000.005.752,570,428.8018,561,265.00https://www.sec.gov/Archives/edgar/data/1661181/000114036119016669/0001140361-19-016669-index.htm
2020-04-22Joshua Alexander TamaroffDirectorBuy18,564.0018,564.00https://www.sec.gov/Archives/edgar/data/1661181/000166118120000023/0001661181-20-000023-index.htm
2019-09-12Avista Capital Managing Member IV, LLCDirectorBuy413,900.006.252,585,343.5718,975,165.00https://www.sec.gov/Archives/edgar/data/1661181/000114036119016669/0001140361-19-016669-index.htm
2019-10-01Brian GrowChief Commercial OfficerBuy667.001.701,133.902,129.00https://www.sec.gov/Archives/edgar/data/1661181/000166118120000004/0001661181-20-000004-index.htm
2020-04-22Arthur S LeibowitzDirectorBuy18,564.0023,564.00https://www.sec.gov/Archives/edgar/data/1661181/000166118120000021/0001661181-20-000021-index.htm
2019-11-26Avista Capital Managing Member IV, LLCDirectorBuy6,000,000.005.0030,000,000.0024,975,165.00https://www.sec.gov/Archives/edgar/data/1661181/000114036119021634/0001140361-19-021634-index.htm
2020-03-12Avista Capital Managing Member IV, LLCDirectorBuy190,887.003.62691,163.6525,166,052.00https://www.sec.gov/Archives/edgar/data/1661181/000114036120005973/0001140361-20-005973-index.htm
2020-03-12Avista Capital Managing Member IV, LLCDirectorBuy141,462.004.17590,377.5125,307,514.00https://www.sec.gov/Archives/edgar/data/1661181/000114036120005973/0001140361-20-005973-index.htm
2020-03-13Avista Capital Managing Member IV, LLCDirectorBuy135,000.004.31581,283.0025,442,514.00https://www.sec.gov/Archives/edgar/data/1661181/000114036120005973/0001140361-20-005973-index.htm
2020-03-16Avista Capital Managing Member IV, LLCDirectorBuy75,000.003.98298,132.5025,517,514.00https://www.sec.gov/Archives/edgar/data/1661181/000114036120005973/0001140361-20-005973-index.htm
2020-04-22Lori FreedmanVP and General CounselBuy26,918.0026,918.00https://www.sec.gov/Archives/edgar/data/1661181/000166118120000016/0001661181-20-000016-index.htm
2020-04-22Timothy M. CunninghamChief Financial OfficerBuy27,847.0027,847.00https://www.sec.gov/Archives/edgar/data/1661181/000166118120000010/0001661181-20-000010-index.htm
2020-04-14Brian GrowChief Commercial OfficerBuy1,150.001.701,955.003,279.00https://www.sec.gov/Archives/edgar/data/1661181/000166118120000004/0001661181-20-000004-index.htm
2020-04-22Brian GrowChief Commercial OfficerBuy32,488.0035,767.00https://www.sec.gov/Archives/edgar/data/1661181/000166118120000012/0001661181-20-000012-index.htm
2020-01-21Antonio S. MontecalvoVP Health Policy & ContractingBuy30,450.001.7051,765.0038,932.00https://www.sec.gov/Archives/edgar/data/1661181/000166118120000006/0001661181-20-000006-index.htm
2020-02-05Gary S. GillheeneyPresident and CEOBuy397,900.001.70676,430.00397,900.00https://www.sec.gov/Archives/edgar/data/1661181/000166118120000002/0001661181-20-000002-index.htm
2020-04-22Gary S. GillheeneyPresident and CEOBuy88,181.00486,081.00https://www.sec.gov/Archives/edgar/data/1661181/000166118120000008/0001661181-20-000008-index.htm
2019-09-03Arthur S LeibowitzDirectorBuy5,000.004.2021,000.005,000.00https://www.sec.gov/Archives/edgar/data/1661181/000166118119000012/0001661181-19-000012-index.htm
2019-09-03WAYNE D MACKIEDirectorBuy50,000.004.31215,705.0050,000.00https://www.sec.gov/Archives/edgar/data/1661181/000166118119000010/0001661181-19-000010-index.htm
2020-04-22Antonio S. MontecalvoVP Health Policy & ContractingBuy24,134.0063,066.00https://www.sec.gov/Archives/edgar/data/1661181/000166118120000006/0001661181-20-000006-index.htm
2019-09-03Alan A. AdesDirectorBuy50,000.004.38218,930.0067,896,723.00https://www.sec.gov/Archives/edgar/data/1661181/000166118119000005/0001661181-19-000005-index.htm
2019-09-03GLENN H NUSSDORFDirectorBuy50,000.004.38218,930.0067,896,723.00https://www.sec.gov/Archives/edgar/data/1661181/000166118119000006/0001661181-19-000006-index.htm
2019-09-03Alan A. AdesDirectorBuy100.004.25425.0067,896,823.00https://www.sec.gov/Archives/edgar/data/1661181/000166118119000005/0001661181-19-000005-index.htm
2019-09-03GLENN H NUSSDORFDirectorBuy100.004.25425.0067,896,823.00https://www.sec.gov/Archives/edgar/data/1661181/000166118119000006/0001661181-19-000006-index.htm
2019-09-04Alan A. AdesDirectorBuy50,000.004.62231,190.0067,946,823.00https://www.sec.gov/Archives/edgar/data/1661181/000166118119000005/0001661181-19-000005-index.htm
2019-09-04GLENN H NUSSDORFDirectorBuy50,000.004.62231,190.0067,946,823.00https://www.sec.gov/Archives/edgar/data/1661181/000166118119000006/0001661181-19-000006-index.htm
2019-09-05Alan A. AdesDirectorBuy5,000.004.5322,664.0067,951,823.00https://www.sec.gov/Archives/edgar/data/1661181/000166118119000005/0001661181-19-000005-index.htm
2019-09-05GLENN H NUSSDORFDirectorBuy5,000.004.5322,664.0067,951,823.00https://www.sec.gov/Archives/edgar/data/1661181/000166118119000006/0001661181-19-000006-index.htm
2019-09-06Alan A. AdesDirectorBuy10,000.005.0350,274.0067,961,823.00https://www.sec.gov/Archives/edgar/data/1661181/000166118119000015/0001661181-19-000015-index.htm
2019-09-06GLENN H NUSSDORFDirectorBuy10,000.005.0350,274.0067,961,823.00https://www.sec.gov/Archives/edgar/data/1661181/000166118119000016/0001661181-19-000016-index.htm
2019-09-04WAYNE D MACKIEDirectorBuy32,000.004.70150,505.6082,000.00https://www.sec.gov/Archives/edgar/data/1661181/000166118119000010/0001661181-19-000010-index.htm
2019-09-09WAYNE D MACKIEDirectorBuy1,000.004.954,950.0083,000.00https://www.sec.gov/Archives/edgar/data/1661181/000166118119000019/0001661181-19-000019-index.htm
2018-12-10David F BurgstahlerPresident & CEOBuy9,022,741.009,022,741.00https://www.sec.gov/Archives/edgar/data/1661181/000114036118045047/0001140361-18-045047-index.htm
2019-09-10WAYNE D MACKIEDirectorBuy8,877.005.1745,895.8791,877.00https://www.sec.gov/Archives/edgar/data/1661181/000166118119000019/0001661181-19-000019-index.htm
2019-09-11WAYNE D MACKIEDirectorBuy3,133.005.8018,171.4095,010.00https://www.sec.gov/Archives/edgar/data/1661181/000166118119000019/0001661181-19-000019-index.htm
2019-09-12WAYNE D MACKIEDirectorBuy3,958.006.1424,302.1298,968.00https://www.sec.gov/Archives/edgar/data/1661181/000166118119000020/0001661181-19-000020-index.htm